Protect the brain you have. Optimise the mind you rely on.
VITALIS Neurolongevity is a specialist pathway for people who want to understand and optimise brain health over time. Through our association with NNI — Noosa Neurocognitive Institute — selected members may access advanced cognitive risk profiling, brain-health diagnostics, digital twin insights, and specialist-led prevention pathways.
“The goal is not simply to detect decline. The goal is to protect cognitive reserve, improve resilience, and act earlier.”
Cognition is biology.
Sleep, metabolism, vascular risk, inflammation, fitness, recovery, medication burden, and stress load all shape the brain. VITALIS integrates these signals into your digital twin — and escalates through NNI when deeper assessment matters.
Who it is for
- · Family history of Alzheimer's / dementia
- · APOE-informed risk where available
- · Subjective memory or attention change
- · Sleep disruption or suspected sleep apnoea
- · Burnout or high cognitive load
- · Cardiometabolic risk
- · Hypertension or vascular risk
- · Insulin resistance / visceral adiposity
- · Executives & professionals seeking cognitive performance
- · Clinicians, founders, athletes, leaders seeking resilience
The biological systems behind cognition.
When deeper assessment matters.
When risk signals or symptoms warrant deeper review, selected VITALIS members may be referred into NNI — Noosa Neurocognitive Institute — for advanced cognitive risk profiling and prevention planning, with results integrated back into your VITALIS digital twin.
Metabolic medicine is brain medicine.
Newer incretin therapies — including dual GLP-1/GIP agonists like tirzepatide — show emerging neuro-relevant effects on inflammation, vascular-cognitive risk, appetite and reward circuitry, and sleep architecture. VITALIS monitors these systems alongside cardiometabolic response, with NNI escalation when deeper assessment is warranted.
See the Cardiometabolic safety architecture →Safety & clinical governance
VITALIS Neurolongevity does not claim to prevent dementia or diagnose neurological disease from app data. It provides a structured, medically governed pathway to identify modifiable risks, monitor cognitive resilience, and escalate appropriately when deeper assessment is needed.